271 – 280 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors
(
- Contribution to journal › Article
-
Mark
Parietal lobe: Activation in rapid, automatized naming by adults
(
- Contribution to journal › Article
-
Mark
Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden.
(
- Contribution to journal › Article
- 2001
-
Mark
Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders
(
- Contribution to journal › Article
-
Mark
Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia
(
- Contribution to journal › Article
-
Mark
Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients
(
- Contribution to journal › Article
-
Mark
Normal or Alzheimer's disease? - Automated interpretation of cerebral blood flow images using artificial neural networks
2001) Congress of the european association of nuclear medicine In European Journal Of Nuclear Medicine 28(8). p.1062-1062(
- Contribution to journal › Published meeting abstract
-
Mark
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice
(
- Contribution to journal › Article